大运亨通
--
LTC Takes the Stage on Wall Street: MEI Pharma's 'Litecoin Treasury' Surges Over 80%
On July 19, the American pharmaceutical company MEI Pharma (stock code: MEIP) announced a strategic transformation to establish a dedicated Litecoin treasury strategy. Currently, over $100 million in funding commitments have been made for this project.
As part of the transaction, this biotech company will appoint Litecoin founder Charlie Lee to its board of directors. GSR will also obtain a board seat and play an important role on the company's digital asset and fund management advisory committee. Additionally, the Litecoin Foundation has also invested in MEI Pharma, as the company's treasury strategy aligns closely with the core mission of promoting global Litecoin adoption.
As part of the transaction, this biotech company will appoint Litecoin founder Charlie Lee to its board of directors. GSR will also obtain a board seat and play an important role on the company's digital asset and fund management advisory committee. Additionally, the Litecoin Foundation has also invested in MEI Pharma, as the company's treasury strategy aligns closely with the core mission of promoting global Litecoin adoption.
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content. See T&Cs.
49
0
Explore the latest crypto news
⚡️ Be a part of the latests discussions in crypto
💬 Interact with your favorite creators
👍 Enjoy content that interests you
Email / Phone number